UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2021-03, Vol.32 (3), p.309-322

2021

Volltextzugriff (PDF)

International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma

Leukemia, 2009-09, Vol.23 (9), p.1545-1556

2009

Volltextzugriff (PDF)

The role of novel agents on the reversibility of renal impairment in newly diagnosed symptomatic patients with multiple myeloma

Leukemia, 2013-02, Vol.27 (2), p.423-429

2013

Volltextzugriff (PDF)

Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy

Journal of ovarian research, 2021-11, Vol.14 (1), p.148-148, Article 148

2021

Volltextzugriff (PDF)

High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer

British journal of cancer, 2013-03, Vol.108 (5), p.1100-1105

2013

Volltextzugriff (PDF)

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management

Leukemia, 2010-06, Vol.24 (6), p.1121-1127

2010

Volltextzugriff (PDF)

Carfilzomib–dexamethasone vs bortezomib–dexamethasone in relapsed or refractory multiple myeloma by cytogenetic risk in the phase 3 study ENDEAVOR

Leukemia, 2017-06, Vol.31 (6), p.1368-1374

2017

Volltextzugriff (PDF)

International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders

Leukemia, 2009-02, Vol.23 (2), p.215-224

2009

Volltextzugriff (PDF)

Prognostic evaluation of tumour type and other histopathological characteristics in advanced epithelial ovarian cancer, treated with surgery and paclitaxel/carboplatin chemotherapy: Cell type is the most useful prognostic factor

European journal of cancer (1990), 2012-07, Vol.48 (10), p.1476-1483

2012

Volltextzugriff (PDF)

Diffuse MRI marrow pattern correlates with increased angiogenesis, advanced disease features and poor prognosis in newly diagnosed myeloma treated with novel agents

Leukemia, 2010-06, Vol.24 (6), p.1206-1212

2010

Volltextzugriff (PDF)

Preserved levels of uninvolved immunoglobulins are independently associated with favorable outcome in patients with symptomatic multiple myeloma

Leukemia, 2014-10, Vol.28 (10), p.2075-2079

2014

Volltextzugriff (PDF)

Renal failure in multiple myeloma: Incidence, correlations, and prognostic significance

Leukemia & lymphoma, 2007-02, Vol.48 (2), p.337-341

2007

Volltextzugriff (PDF)

Docetaxel and Cisplatin With Granulocyte Colony-Stimulating Factor (G-CSF) Versus MVAC With G-CSF in Advanced Urothelial Carcinoma: A Multicenter, Randomized, Phase III Study From the Hellenic Cooperative Oncology Group

Journal of clinical oncology, 2004-01, Vol.22 (2), p.220-228

2004

Volltextzugriff (PDF)

Prognostic significance of magnetic resonance imaging of bone marrow in previously untreated patients with multiple myeloma

Annals of oncology, 2005-11, Vol.16 (11), p.1824-1828

2005

Volltextzugriff (PDF)

The International Scoring System (ISS) for multiple myeloma remains a robust prognostic tool independently of patients’ renal function

Annals of oncology, 2012-03, Vol.23 (3), p.722-729

2012

Volltextzugriff (PDF)

randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer

Cancer chemotherapy and pharmacology, 2010-05, Vol.65 (6), p.1009-1021

2010

Volltextzugriff (PDF)

Evaluation of Reliability and Validity of the RALE and BRIXIA Chest-X Ray Scores in Patients Hospitalized with COVID-19 Pneumonia

Romanian Journal of Internal Medicine, 2023-09, Vol.61 (3), p.141-146

2023

Volltextzugriff (PDF)

Waldenström’s Macroglobulinemia: Clinical Features, Complications, and Management

Journal of clinical oncology, 2000-01, Vol.18 (1), p.214-226

2000

Volltextzugriff (PDF)

Development and validation of a prognostic model in patients with metastatic renal cell carcinoma treated with sunitinib: a European collaboration

British journal of cancer, 2013-07, Vol.109 (2), p.332-341

2013

Volltextzugriff (PDF)

Evaluation of the prognostic and predictive value of HER family mRNA expression in high-risk early breast cancer: A Hellenic Cooperative Oncology Group (HeCOG) study

British journal of cancer, 2008-12, Vol.99 (11), p.1775-1785

2008

Volltextzugriff (PDF)

Low-grade mucosa-associated lymphoid tissue lymphoma: a retrospective analysis of 97 patients by the Hellenic Cooperative Oncology Group (HeCOG)

Annals of oncology, 2008-04, Vol.19 (4), p.780-786

2008

Volltextzugriff (PDF)

Systemic chemotherapy in inoperable or metastatic bladder cancer

Annals of oncology, 2006-04, Vol.17 (4), p.553-561

2006

Volltextzugriff (PDF)

The outcome of elderly patients with advanced urothelial carcinoma after platinum-based combination chemotherapy

Annals of oncology, 2005-02, Vol.16 (2), p.307-313

2005

Volltextzugriff (PDF)

1 – 25 von 159

Suche als RSS-Feed

Aktive Filter

ThemaPrognosis

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(156)
Mit Volltextzugriff
(141)

Publikationsform

Artikel
(159)

Sprache

Englisch
(158)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(157)
Science & Technology
(147)
Life Sciences & Biomedicine
(146)
Female
(114)
Middle Aged
(98)
Aged
(91)
Male
(91)
Oncology
(85)
Adult
(84)
Biological And Medical Sciences
(69)
Medical Sciences
(69)
Hematology
(56)
Aged, 80 And Over
(47)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(41)
Treatment Outcome
(36)
Survival Analysis
(32)
Survival Rate
(32)
Multiple Myeloma
(29)
Neoplasm Staging
(29)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study

Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group

International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma

The role of novel agents on the reversibility of renal impairment in newly diagnosed symptomatic patients with multiple myeloma

Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy

High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management

Carfilzomib–dexamethasone vs bortezomib–dexamethasone in relapsed or refractory multiple myeloma by cytogenetic risk in the phase 3 study ENDEAVOR

International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders

Prognostic evaluation of tumour type and other histopathological characteristics in advanced epithelial ovarian cancer, treated with surgery and paclitaxel/carboplatin chemotherapy: Cell type is the most useful prognostic factor

Diffuse MRI marrow pattern correlates with increased angiogenesis, advanced disease features and poor prognosis in newly diagnosed myeloma treated with novel agents

Preserved levels of uninvolved immunoglobulins are independently associated with favorable outcome in patients with symptomatic multiple myeloma

Renal failure in multiple myeloma: Incidence, correlations, and prognostic significance

Docetaxel and Cisplatin With Granulocyte Colony-Stimulating Factor (G-CSF) Versus MVAC With G-CSF in Advanced Urothelial Carcinoma: A Multicenter, Randomized, Phase III Study From the Hellenic Cooperative Oncology Group

Prognostic significance of magnetic resonance imaging of bone marrow in previously untreated patients with multiple myeloma

The International Scoring System (ISS) for multiple myeloma remains a robust prognostic tool independently of patients’ renal function

randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer

Evaluation of Reliability and Validity of the RALE and BRIXIA Chest-X Ray Scores in Patients Hospitalized with COVID-19 Pneumonia

Waldenström’s Macroglobulinemia: Clinical Features, Complications, and Management

Development and validation of a prognostic model in patients with metastatic renal cell carcinoma treated with sunitinib: a European collaboration

Evaluation of the prognostic and predictive value of HER family mRNA expression in high-risk early breast cancer: A Hellenic Cooperative Oncology Group (HeCOG) study

Low-grade mucosa-associated lymphoid tissue lymphoma: a retrospective analysis of 97 patients by the Hellenic Cooperative Oncology Group (HeCOG)

Systemic chemotherapy in inoperable or metastatic bladder cancer

The outcome of elderly patients with advanced urothelial carcinoma after platinum-based combination chemotherapy

Aktive Filter

Suchergebnisse filtern